Document Detail


Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy.
MedLine Citation:
PMID:  20467363     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Graves' orbitopathy (GO) is part of an autoimmune disease, in which TSH-receptor antibodies (TRAb) stimulate the target organs. Most of these patients develop hyperthyroidism and about half an orbitopathy. To ensure the diagnosis, TRAb are determined, especially in patients with GO without associated thyroid disease. Because of their significantly improved sensitivity and equal specificity, second generation TRAb-assays should be preferred. Persisting high TRAb levels are associated with a severe course of GO. TRAb cut off levels are available for prognostic statements during the course of GO and can be applied for crucial treatment decisions. Persisting high TRAb levels are also associated with low remission rates of hyperthyroidism. TRAb cut off levels are available for prognostic statements at 6, 12 and 18 months after the beginning of antithyroid drug treatment. Definitive treatment of the thyroid can be decided early on this basis, which is an advantage for ophthalmosurgical rehabilitation.
Authors:
A Eckstein; J Esser; K Mann; M Schott
Related Documents :
3368333 - Highly sensitive determination of tsh in the follow-up of tsh-suppressive therapy of pa...
6407253 - A study of thyroid function after subtotal thyroidectomy for graves' disease: particula...
17636543 - Voice quality after co2 laser cordectomy--what can we really expect?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pediatric endocrinology reviews : PER     Volume:  7 Suppl 2     ISSN:  1565-4753     ISO Abbreviation:  Pediatr Endocrinol Rev     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-05-14     Completed Date:  2010-06-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101202124     Medline TA:  Pediatr Endocrinol Rev     Country:  Israel    
Other Details:
Languages:  eng     Pagination:  198-203     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, University Duisburg-Essen, Germany. anja.eckstein@uk-essen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Graves Ophthalmopathy / diagnosis*,  immunology*
Humans
Immunoglobulins, Thyroid-Stimulating / blood*
Prognosis
Receptors, Thyrotropin / immunology*
Recurrence
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Immunoglobulins, Thyroid-Stimulating; 0/Receptors, Thyrotropin; 0/thyrotropin-binding inhibitory immunoglobulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
Next Document:  Corticosteroids in the medical treatment of thyroid ophthalmopathy: when and how? Somatostatin analo...